Review: Lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis

Veterinary Dermatology

Volumn 26, Issue 2, 2015, Pages 124-e32

  Pucheu Haston, Cherie M ^a   Bizikova, Petra ^b   Marsella, Rosanna ^c   Santoro, Domenico ^c   Nuttall, Tim ^d   Eisenschenk, Melissa N C ^e  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c University of Florida   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Pet Dermatology Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

CHEMOKINE; CYTOKINE;

ANIMAL; ATOPIC DERMATITIS; CLASSIFICATION; DOG; DOG DISEASE; GENETICS; HELPER CELL; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PHYSIOLOGY; VETERINARY;

ANIMALS; CHEMOKINES; CYTOKINES; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84925361780     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12205     Document Type: Review

References (64)

1. Hill PB, Olivry T. The ACVD task force on canine atopic dermatitis (V): biology and role of inflammatory cells in cutaneous allergic reactions. Vet Immunol Immunopathol 2001; 81: 187-198.
2. Marsella R, Olivry T. The ACVD task force on canine atopic dermatitis (VII): mediators of cutaneous inflammation. Vet Immunol Immunopathol 2001; 81: 205-213.
3. Thepen T, Langeveld-Wildschut EG, Bihari IC et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996; 97: 828-837.
4. Werfel T, Morita A, Grewe M et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996; 107: 871-876.
5. Reinhold U, Kukel S, Goeden B et al. Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991; 86: 444-448.
6. van der Heijden FL, Wierenga EA, Bos JD et al. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97: 389-394.
7. Olivry T, Naydan DK, Moore PF. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. Am J Dermatopathol 1997; 19: 477-486.
8. Sinke JD, Thepen T, Bihari IC et al. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Vet Immunol Immunopathol 1997; 57: 13-23.
9. Olivry T, Dean GA, Tompkins MB et al. Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs. Exp Dermatol 1999; 8: 204-211.
10. Nimmo Wilkie JS, Wilkie BN, Yager JA et al. Altered spontaneous and histamine-induced in vitro suppressor-cell function in dogs with atopic dermatitis. Vet Immunol Immunopathol 1992; 30: 129-145.
11. Nimmo Wilkie JS, Yager JA, Wilkie BN et al. Abnormal cutaneous response to mitogens and a contact allergen in dogs with atopic dermatitis. Vet Immunol Immunopathol 1991; 28: 97-106.
12. Marsella R, Olivry T, Maeda S. Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles. Vet Dermatol 2006; 17: 111-120.
13. Olivry T, Deangelo KB, Dunston SM et al. Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis. Vet Dermatol 2006; 17: 95-102.
14. Marsella R, Olivry T, Nicklin C et al. Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs. Vet Dermatol 2006; 17: 24-35.
15. Pucheu-Haston CM, Jackson HA, Olivry T et al. Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis. Clin Exp Allergy 2008; 38: 667-679.
16. Olivry T, Dunston SM, Murphy KM et al. Characterization of the inflammatory infiltrate during IgE-mediated late phase reactions in the skin of normal and atopic dogs. Vet Dermatol 2001; 12: 49-58.
17. Maeda S, Tsukui T, Saze K et al. Production of a monoclonal antibody to canine thymus and activation-regulated chemokine (TARC) and detection of TARC in lesional skin from dogs with atopic dermatitis. Vet Immunol Immunopathol 2005; 103: 83-92.
18. Maeda S, Ohmori K, Yasuda N et al. Increase of CC chemokine receptor 4-positive cells in the peripheral CD4 cells in dogs with atopic dermatitis or experimentally sensitized to Japanese cedar pollen. Clin Exp Allergy 2004; 34: 1467-1473.
19. Simpson A, Maeda S, Marsella R. Temporal dynamic changes of phenotypic expression of peripheral CD4 cells during environmental allergen challenge in an experimental model of canine atopic dermatitis: a pilot study. J Vet Med Sci 2009; 71: 1177-1181.
20. Maeda S, Okayama T, Omori K et al. Expression of CC chemokine receptor 4 (CCR4) mRNA in canine atopic skin lesion. Vet Immunol Immunopathol 2002; 90: 145-154.
21. Tarpataki N, Terenyi M, Nagy SZ. Changes in the CD4/CD8-positive T lymphocyte ratio in the blood of atopic and non-atopic dogs. Vet Dermatol 2012; 23 (Suppl 1): 58 (abstract).
22. Olivry T, Wofford J, Paps JS et al. Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs. Vet Dermatol 2011; 22: 188-196.
23. Masuda K, Yasuda N. The antibody against human CD25, ACT-1, recognizes canine T-lymphocytes in the G2/M and G0/G1 phases of the cell cycle during proliferation. J Vet Med Sci 2008; 70: 1285-1287.
24. + cells in canine peripheral blood. J Vet Med Sci 2009; 71: 1561-1568.
25. Abbas AK, Lichtman AH, Pillai S (eds). Immunologic tolerance and autoimmunity. In: Cellular and Molecular Immunology. Philadelphia, PA: Elsevier Saunders, 2012; 326.
26. Abbas AK, Lichtman AH, Pillai S (eds). Activation of T lymphocytes. In: Cellular and Molecular Immunology. 7th edition. Philadelphia, PA: Elsevier Saunders, 2012; 210.
27. Garden OA, Pinheiro D, Cunningham F. All creatures great and small: regulatory T cells in mice, humans, dogs and other domestic animal species. Int Immunopharmacol 2011; 11: 576-588.
28. Lin T-Y, London CA. A functional comparison of canine and murine bone marrow derived cultured mast cells. Vet Immunol Immunopathol 2006; 114: 320-334.
29. Archer TM, Fellman CL, Stokes JV et al. Pharmacodynamic monitoring of canine T-cell cytokine responses to oral cyclosporine. J Vet Intern Med 2011; 25: 1391-1397.
30. Nuttall TJ, Knight PA, McAleese SM et al. Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis. Clin Exp Allergy 2002; 32: 789-795.
31. Maeda S, Fujiwara S, Omori K et al. Lesional expression of thymus and activation-regulated chemokine in canine atopic dermatitis. Vet Immunol Immunopathol 2002; 88: 79-87.
32. Schlotter YM, Rutten VP, Riemers FM et al. Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness. Vet Immunol Immunopathol 2011; 143: 20-26.
33. Pucheu-Haston CM, Shuster D, Olivry T et al. A canine model of cutaneous late-phase reactions: prednisolone inhibition of cellular and cytokine responses. Immunology 2006; 117: 177-187.
34. Maeda S, Tsuchida H, Marsella R. Allergen challenge decreases mRNA expression of regulatory cytokines in whole blood of high-IgE beagles. Vet Dermatol 2007; 18: 422-426.
35. Fujiwara S, Yasunaga S, Iwabuchi S et al. Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Vet Immunol Immunopathol 2003; 93: 9-20.
36. Shida M, Kadoya M, Park SJ et al. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis. Vet Immunol Immunopathol 2004; 102: 19-31.
37. Mueller RS, Veir J, Fieseler KV et al. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study. Vet Dermatol 2005; 16: 61-68.
38. McCandless EE, Rugg CA, Fici GJ et al. Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells. Vet Immunol Immunopathol 2014; 157: 42-48.
39. Klukowska-Rötzler J, Chervet L, Müller EJ et al. Expression of thymic stromal lymphopoietin in canine atopic dermatitis. Vet Dermatol 2013; 24: 54-59.
40. Mizuno T, Kanbayashi S, Okawa T et al. Molecular cloning of canine interleukin-31 and its expression in various tissues. Vet Immunol Immunopathol 2009; 131: 140-143.
41. Gonzales AJ, Humphrey WR, Messamore JE et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013; 24: 48-53, e11-e12.
42. Plager DA, Torres SM, Koch SN et al. Gene transcription abnormalities in canine atopic dermatitis and related human eosinophilic allergic diseases. Vet Immunol Immunopathol 2012; 149: 136-142.
43. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 2006; 36: 1357-1366.
44. Schroder K, Hertzog PJ, Ravasi T et al. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163-189.
45. Hayashiya S, Tani K, Morimoto M et al. Expression of T helper 1 and T helper 2 cytokine mRNAs in freshly isolated peripheral blood mononuclear cells from dogs with atopic dermatitis. J Vet Med A Physiol Pathol Clin Med 2002; 49: 27-31.
46. Vignali DAA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol 2012; 13: 722-728.
47. Abdi K. IL-12: the role of p40 versus p75. Scand J Immunol 2002; 56: 1-11.
48. Ma X, D'Andrea A, Kubin M et al. Production of interleukin-12. Res Immunol 1995; 146: 432-438.
49. D'Andrea A, Rengaraju M, Valiante NM et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176: 1387-1398.
50. Goodman WA, Young AB, McCormick TS et al. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression. J Immunol 2011; 186: 3336-3345.
51. Keppel KE, Campbell KL, Zuckermann FA et al. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Vet Immunol Immunopathol 2008; 123: 337-344.
52. Maeda S, Tsuchida H, Shibata S et al. Expression analysis of CCL27 and CCL28 mRNA in lesional and non-lesional skin of dogs with atopic dermatitis. J Vet Med Sci 2008; 70: 51-55.
53. Nuttall T, Knight PA, McAleese SM et al. Expression of T-helper 1 cytokine mRNA in canine atopic dermatitis correlates with clinical severity. In: Hillier A, Foster AP, Kwochka KW, eds. Advances in Veterinary Dermatology, volume 5. Oxford, UK: Blackwell Publishing, 2004; 17-27.
54. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-340.
55. Chung TH, Oh JS, Lee YS et al. Elevated serum levels of S100 calcium binding protein A8 (S100A8) reflect disease severity in canine atopic dermatitis. J Vet Med Sci 2010; 72: 693-700.
56. Merryman-Simpson AE, Wood SH, Fretwell N et al. Gene (mRNA) expression in canine atopic dermatitis: microarray analysis. Vet Dermatol 2008; 19: 59-66.
57. Wood SH, Clements DN, Ollier WE et al. Gene expression in canine atopic dermatitis and correlation with clinical severity scores. J Dermatol Sci 2009; 55: 27-33.
58. Salzmann CA, Olivry TJ, Nielsen DM et al. Genome-wide linkage study of atopic dermatitis in West Highland White Terriers. BMC Genet 2011; 12: 37-42.
59. Murakami A, Nakagawa T, Kaneko M et al. Suppression of SCC antigen promotes cancer cell invasion and migration through the decrease in E-cadherin expression. Int J Oncol 2006; 29: 1231-1235.
60. Murakami A, Fukushima C, Yositomi K et al. Tumor-related protein, the squamous cell carcinoma antigen binds to the intracellular protein carbonyl reductase. Int J Oncol 2010; 36: 1395-1400.
61. Eklund KK, Niemi K, Kovanen P. Immune functions of serum amyloid A. Crit Rev Immunol 2012; 32: 335-348.
62. Harper JI, Godwin H, Green A et al. A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis. Br J Dermatol 2010; 162: 397-403.
63. Katoh N, Hirano S, Suehiro M et al. Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis. Clin Exp Immunol 2002; 127: 283-288.
64. Nishio Y, Noguchi E, Shibasaki M et al. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 2003; 4: 515-517.